SNTI Stock: Senti Biosciences, Inc. Stock Price, Analysis & Insights
Get live SNTI stock price $0.91, comprehensive Senti Biosciences, Inc. stock analysis, charts, news, and expert forecast. Real-time SNTI stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Senti Biosciences, Inc. is a pioneering company specializing in gene circuit technology. They focus on creating advanced cell and gene therapies that incorporate sophisticated gene circuits, essentially biological computers, to genetically reprogram ...
Company Information
- CEO
- Timothy K. Lu
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 34
Contact Information
- Website
- https://www.sentibio.com
- Address
- 2 Corporate Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 2.09)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Senti Biosciences, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Senti Biosciences, Inc.
- ⚠Investors should consider how Senti Biosciences, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
23.81M
P/E Ratio (TTM)
-0.62
Beta
2.09
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare SNTI with peer companies:
- Price
- $5.14
- Market cap
- 31.81M
- Price
- $0.72
- Market cap
- 29.57M
- Price
- $16.40
- Market cap
- 57.63M
- Price
- $30.44
- Market cap
- 79.99M
- Price
- $1.30
- Market cap
- 8.93M
- Price
- $1.60
- Market cap
- 30.63M
- Price
- $2.21
- Market cap
- 191.32M
- Price
- $8.69
- Market cap
- 196.94M
- Price
- $0.32
- Market cap
- 7.11M
- Price
- $3.85
- Market cap
- 363.13M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.